Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors (FONTANA)
NCT 05797168 Brief Summary This research is designed to determine if experimental…
Read more arrow_forwardNCT 05797168 Brief Summary This research is designed to determine if experimental…
Read more arrow_forwardNCT 05870748 Brief Summary A Phase 2/3 study to investigate the…
Read more arrow_forwardNCT 06132958 Brief Summary Researchers are looking for new ways to treat…
Read more arrow_forwardNCT 04262466 Brief Summary Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell…
Read more arrow_forwardNCT 05544552 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardNCT 05611931 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forwardNCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 05919537 Brief Summary This is a phase 1b multi-center, open-label study…
Read more arrow_forward